Cytek Biosciences (CTKB) Change in Cash (2020 - 2026)

Cytek Biosciences has reported Change in Cash for 7 years, with the latest figure at -$25.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 630.93% year-over-year to -$25.2 million; the trailing twelve-month figure through Mar 2026 stood at -$29.6 million (up 59.87% YoY), and the FY2025 full-year result was -$7.9 million, up 88.54% from the prior year.
• Change in Cash for Q1 2026 stood at -$25.2 million, down from -$2.4 million in the prior quarter.
• The five-year high for Change in Cash was $32.1 million in Q3 2023, with the low at -$167.1 million in Q1 2023.
• Historically, Change in Cash has averaged -$17.6 million across 5 years, with a median of -$3.4 million in 2025.
• Annual changes were most pronounced in 2023 — Change in Cash tumbled 7812.22% — and 2024, when it surged 1132.59%.
• Cytek Biosciences' Change in Cash stood at -$42.0 million in 2022, then surged by 109.52% to $4.0 million in 2023, then plunged by 1688.55% to -$63.6 million in 2024, then soared by 96.18% to -$2.4 million in 2025, then tumbled by 937.82% to -$25.2 million in 2026.
• The last three Change in Cash figures came in at -$25.2 million (Q1 2026), -$2.4 million (Q4 2025), and $17.8 million (Q3 2025), per Business Quant data.